Vista Pharmaceuticals Ltd

BSE: 524711

total announcements

VISTAPH.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 06 Oct 2026

Market Cap

₹36 Cr

EPS (TTM)

₹-1.92

52W Low

₹5.32

52W High

₹10.50

Dividend Yield

0.00%

Beta

0.05

Price / Book

0.8

Return on Equity

-16.57%

Revenue (TTM)

₹9 Cr

Gross Margin

6.08%

Operating Margin

-2584.21%

Announcements Discussion

BSEBoard Meeting▼ NegativeResults14 Aug 2026

Vista Pharmaceuticals Ltd

Results for the quarter ended 30.06.2026

Vista Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended 30.06.2026, reporting a net loss of Rs. (132.71) Lakhs compared to a loss of Rs. (148.01) Lakhs in the corresponding quarter of the previous year. The revenue from operations for the current quarter is Nil compared to Rs. 151.88 Lakhs for the corresponding quarter of the previous year.

Results for the quarter ended 30.06.2026

Vista Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended 30.06.2026, reporting a net loss of Rs. (98.59) lakhs compared to a loss of Rs. (129.04) lakhs in the corresponding quarter of the previous year. The revenue from operations for the current quarter is Nil compared to Rs. 151.88 lakhs for the corresponding quarter of the previous year. The company has also issued 10,243,998 Convertible Share Warrants and received 25% of the upfront subscription amounting to INR 307.50 lakhs.

Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. Unaudited financial ....

Vista Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve unaudited financial results for the quarter ended 30.06.2026.